Navigation Links
Monogram Biosciences to Present at the JMP Securities Healthcare Conference
Date:10/10/2007

SOUTH SAN FRANCISCO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that Alfred G. Merriweather, Senior Vice President and Chief Financial Officer, is scheduled to present a corporate overview at the JMP Securities Healthcare Conference on Tuesday, November 13, 2007 at 11:00 a.m. (Eastern Time) at the Four Seasons Hotel in Boston, Massachusetts.

To access the live audio broadcast or the subsequent archived recording, log on to http://www.monogrambio.com and go to the investor relations section ("Investors/Media" tab) and click on the "Events & Webcasts" link provided on the sidebar menu on the page.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com.

Contacts: Alfred G. Merriweather

Chief Financial Officer

Tel: 650 624-4576

amerriweather@monogrambio.com

Jeremiah Hall

Feinstein Kean Healthcare<
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Investor-Edge has initiated coverage on the following ... (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: ... and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on ... . On Wednesday, October 29, 2014, the ... Jones Industrial Average declined 0.18%, to finish the day ...
(Date:10/30/2014)... 2014 On October 26th at ... in Chicago, leading applied stem cell research scientist ... McKenna presented talks on New Techniques for Enhancing ... For Stem Cells. , Dr. Riordan focused on ... properties of AlphaGEMS that include: wound healing; inflammation ...
(Date:10/30/2014)... Ottawa, Ontario (PRWEB) October 30, 2014 ... the Spartan RX CYP2C19 System . It detects ... a non-invasive cheek swab. , The Spartan RX CYP2C19 ... medicine that has been approved in Canada. Due to ... that it may be used by healthcare professionals such ...
(Date:10/30/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader ... company overview at the Nomura Biotechnology Conference on Thursday, November ... MA. A live webcast of the ... of the Company,s website, www.isispharm.com .  A replay will ... will be archived for a limited time. About ...
Breaking Biology Technology:Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... and simple way of making vaccines stable even ... by scientists at Oxford University. The British technology, ... need for fridges, freezers and associated health infrastructure. It ... in the developing world where infectious diseases kill millions ...
... ... , ... 2010 -- iCorps Technologies , a leader in delivering solid, business-driven IT solutions ... Technology Industry Association (CompTIA) is the leading trade association for the world,s information technology ...
... , Feb. 17 Anpath Group, Inc. (OTC Bulletin ... financial results for its fiscal 2010 third quarter which ended ... , The Company continued a positive trend of increased ... third quarter were $66,988 compared with revenues of ...
Cached Biology Technology:New method makes vaccines stable at tropical temperatures 2New method makes vaccines stable at tropical temperatures 3iCorps Technologies Earns CompTIA Security Trustmark&#8482; 2iCorps Technologies Earns CompTIA Security Trustmark&#8482; 3Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 2Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 3Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 4
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... on sunlight to make their food, but they also need ... scientists discovered a group of molecules in plants that shields ... Journal of the American Chemical Society , one team ... work. , Timothy Zwier and colleagues at Purdue University note ... can cause serious damage to plant DNA and, as a ...
(Date:10/29/2014)... New York City on September 19, 2014, leading geneticist ... Professor of Genome Sciences and Medicine at the University ... Philosophy of Tel Aviv University, was awarded the 2014 ... addition to her honorary degree from TAU, Prof. King ... of Medicine, and for the past 18 years she ...
Breaking Biology News(10 mins):HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Geneticist and humanitarian: Prof. Mary-Claire King receives Lasker Award 2
... Scientists looking to create a potent blend of enzymes to ... have developed a test that should turbocharge their efforts. ... Molecular BioSystems , is part of a worldwide effort to ... of the food supply. It,s possible to do this today, ...
... , PHILADELPHIA - It,s well established that humans maintain ... that colonize their bodies. These organisms, collectively called the ... off pathogens, and more. There exists a long and ... composition or diversity of these bacterial populations, including cancer, ...
... from the National Cancer Centre Singapore, Duke-NUS Graduate Medical ... University (Thailand), have made a seminal breakthrough in understanding ... a rare but highly lethal form of liver cancer. ... Tan, Steve Rozen, Irinel Popescu and Vajaraphongsa Bhudhisawasdi, used ...
Cached Biology News:Crafting a better enzyme cocktail to turn plants into fuel faster 2Crafting a better enzyme cocktail to turn plants into fuel faster 3Penn researchers identify molecular link between gut microbes and intestinal health 2Penn researchers identify molecular link between gut microbes and intestinal health 3Singapore scientists expose molecular secrets of bile duct cancers from different countries 2Singapore scientists expose molecular secrets of bile duct cancers from different countries 3
Rabbit monoclonal [E227] to ZAP70 (phospho Y319) ( Abpromise for all tested applications). Antigen: Synthetic phospho peptide corresponding to residues surrounding Tyr319 of human ZAP70 Entre...
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Mouse monoclonal [GB3] to Kalinin ( Abpromise for all tested applications). entrezGeneID: 3918 SwissProtID: Q13753...
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
Biology Products: